| Schedule of information regarding reportable segments |
| | | | | | | | | | | | | | | Three Months | | Six Months | For the Periods Ended December 31 | | 2024 | | 2023 | | 2024 | | 2023 | Net sales | | | | | | | | | | | | | Animal Health | | $ | 229,418 | | $ | 173,104 | | $ | 411,941 | | $ | 333,634 | Mineral Nutrition | | | 63,250 | | | 61,347 | | | 122,312 | | | 117,373 | Performance Products | | | 16,593 | | | 15,492 | | | 35,440 | | | 30,285 | Total segments | | $ | 309,261 | | $ | 249,943 | | $ | 569,693 | | $ | 481,292 | | | | | | | | | | | | | | Depreciation and amortization | | | | | | | | | | | | | Animal Health | | $ | 10,286 | | $ | 7,348 | | $ | 17,949 | | $ | 14,697 | Mineral Nutrition | | | 515 | | | 660 | | | 1,031 | | | 1,306 | Performance Products | | | 292 | | | 433 | | | 625 | | | 859 | Total segments | | $ | 11,093 | | $ | 8,441 | | $ | 19,605 | | $ | 16,862 | Adjusted EBITDA | | | | | | | | | | | | | Animal Health | | $ | 58,177 | | $ | 39,299 | | $ | 98,561 | | $ | 67,793 | Mineral Nutrition | | | 5,702 | | | 3,507 | | | 9,464 | | | 6,388 | Performance Products | | | 1,888 | | | 817 | | | 4,177 | | | 2,226 | Total segments | | $ | 65,767 | | $ | 43,623 | | $ | 112,202 | | $ | 76,407 | Reconciliation of income before income taxes to Adjusted EBITDA | | | | | | | | | | | | | Income (loss) before income taxes | | $ | 4,838 | | $ | 3,565 | | $ | 14,458 | | $ | (8,414) | Interest expense, net | | | 8,996 | | | 4,659 | | | 16,637 | | | 9,223 | Depreciation and amortization – Total segments | | | 11,093 | | | 8,441 | | | 19,605 | | | 16,862 | Depreciation and amortization – Corporate | | | 481 | | | 469 | | | 973 | | | 919 | Corporate costs | | | 17,592 | | | 14,171 | | | 33,371 | | | 28,304 | Acquisition-related cost of goods sold | | | 1,634 | | | 310 | | | 1,634 | | | 310 | Acquisition-related other | | | 8,815 | | | — | | | 12,239 | | | — | Pension settlement cost | | | — | | | 249 | | | — | | | 10,674 | Brazil employment taxes | | | — | | | 4,202 | | | — | | | 4,202 | Insurance settlement gain | | | (1,257) | | | — | | | (1,257) | | | — | Stock-based compensation expense | | | 180 | | | 80 | | | 359 | | | 161 | Phibro Forward income growth initiatives | | | 1,696 | | | — | | | 2,046 | | | — | Foreign currency losses, net | | | 11,699 | | | 7,477 | | | 12,137 | | | 14,166 | Adjusted EBITDA – Total segments | | $ | 65,767 | | $ | 43,623 | | $ | 112,202 | | $ | 76,407 |
|
| Schedule of identifiable assets |
| | | | | | | | | December 31, | | June 30, | As of | | 2024 | | 2024 | Identifiable assets | | | | | | | Animal Health | | $ | 1,011,145 | | $ | 684,407 | Mineral Nutrition | | | 76,950 | | | 67,088 | Performance Products | | | 50,998 | | | 50,862 | Total segments | | | 1,139,093 | | | 802,357 | Corporate | | | 146,416 | | | 179,827 | Total | | $ | 1,285,509 | | $ | 982,184 |
|